Understanding Patient and Physician Views on Benign Prostatic Hyperplasia in Europe
Author Information
Author(s): Mark Emberton, Marberger M, de la Rosette J
Primary Institution: Institute of Urology and Nephrology, University College London
Hypothesis
What are the healthcare-seeking behaviors and attitudes towards BPH treatment among patients and urologists in Europe?
Conclusion
The study reveals significant discrepancies between patient and physician beliefs regarding BPH management in Europe.
Supporting Evidence
- 85% of patients reported their condition was discovered through symptoms rather than routine examination.
- 72% of patients received a prescription medication for BPH symptoms on their first or second consultation.
- 80% of 5α-reductase inhibitor users were satisfied with their treatment compared to 68% of α-blocker users.
- 87% of urologists believe that BPH progresses.
- More than three-quarters of patients preferred a drug that reduces the risk of surgery over one that provides rapid symptom relief.
Takeaway
This study shows that many men with prostate problems worry about surgery and want treatments that prevent complications, not just relieve symptoms.
Methodology
The PROBE survey included questionnaires for 502 BPH patients and 100 urologists across five European countries.
Potential Biases
Interviewer bias and the influence of the survey's design may affect responses.
Limitations
The survey is limited by potential biases in question wording and the lack of statistical analysis.
Participant Demographics
Participants included men aged 45-80 with a history of prostate problems from France, Germany, Italy, Spain, and the UK.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website